| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |